Generation of monoclonal antibodies to cryptic collagen sites by using subtractive immunization

Hybridoma

Volumn 19, Issue 5, 2000, Pages 375-385

  Xu, J ^a   Rodriguez, D ^a   Kim, J J ^a   Brooks, P C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; EPITOPE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HYBRIDOMA; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYBRIDOMAS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MICE; PROTEIN DENATURATION; SACCHAROMYCES CEREVISIAE PROTEINS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033709053     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/02724570050198893     Document Type: Article

References (38)

1. Structure and biological activity of basement membrane proteins
2. Cell motility and the extracellular matrix
3. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis
4. Regulation of development and differentiation by the extracellular matrix
5. Signal transduction from the extracellular matrix
6. Collagen family of proteins
7. Collagens: Molecular biology, diseases, and potentials for therapy
8. New insights into the function of collagens from genetic analysis
9. Changing views of the matrix metalloproteinases in metastasis
10. Biology and biochemistry of proteinases in tumor invasion
11. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
12. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
13. Localization of matrix metalloproteinase MMP-2 to the surface of invasire cells by interaction with integrin αvβ3
14. Antibodies to distinct types of collagen and procollagens and their applications in immunohistology
15. Monoclonal antibody to type-IV collagen with selective basement membrane localization
16. Immunohistochemical distribution of type-IV collagenase in normal, benign, and malignant breast tissue
17. Subtractive immunization techniques for the production of monoclonal antibodies to rare antigens
18. Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis
19. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
20. Antiintegrin αvβ3 human breast cancer growth and angiogenesis in human skin
21. Preparation of monoclonal antibodies: Strategies and procedures
22. J Cell Physiol
23. Proteolytic balance and capillary morphogenesis
24. The ehlers-danlos syndrome: A heritable collagen disorder as cause of bleeding
25. Integrin αvβ3 promotes M21 melanoma growth in human skin by regulating tumor cell survival
26. New functions for noncollagenous domains of human collagen type-IV: Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo
27. Quantitative immunoassays for type-II collagen and its cyanogen bromide peptides
28. Damage to type-II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration
29. Enhanced cleavage of type-II collagen by collagenase in osteoarthritis articular cartilage
30. Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody
31. The carboxylpropeptide of type-I procollagen in skin fibrillogenesis
32. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases
33. Aggressive breast cancer leads to discrepant serum levels of the type-I procollagen propeptides PINP and PICP
34. Monitoring fibrillar collagen turnover in hypertensive heart disease
35. Mechanisms of antigen-induced blockade of immune response and cyclophosphamide-promoted tolerance to Salmonella typhi Vi antigen
36. On the mechanism of immunological tolerance in cyclophosphamide-treated mice
37. Comparison of two techniques for targeting the production of monoclonal antibodies against particular antigens
38. Cyclophosphamide treatment used to manipulate the immune response for the production of mono-clonal antibodies